ARXS

Arxis, Inc.

SEC CIK 2093536
$43.50 +12.3% · 90 days
90-day buys
$5.64M
7 open-market
90-day sells
$0
0 open-market
Net insider flow
+$5.64M
Net buying
Filings shown
16
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ARXS have bought a net $5.64M of stock (7 open-market buys vs 0 sells).

Largest recent trade: Roth Jason Aaron, ARXS's See Remarks, spent $1.68M of their own money on 60,000 shares at $28, growing their stake 18%.

Insider transaction history

Form 4 filings for ARXS, newest first
View on SEC EDGAR ↗
ARXS
Buy Jankowski Ryan Anthony · Chief Accounting Officer · Open-market purchase · filed Apr 20, 2026 ΔOwn +9.5%

Jankowski Ryan Anthony, ARXS's Chief Accounting …, spent $125K of their own money on 4,464 shares at $28, growing their stake 10%.

+$125K
4,464 sh @ $28
ARXS
Buy Badakhsh Azad Sid · See Remarks · Open-market purchase · filed Apr 20, 2026 ΔOwn +9.8%

Badakhsh Azad Sid, ARXS's See Remarks, spent $1.01M of their own money on 36,000 shares at $28, growing their stake 10%.

+$1.01M
36,000 sh @ $28
ARXS
Buy Sealfon Ross Bradley · See Remarks · Open-market purchase · filed Apr 20, 2026 ΔOwn +1.1%

Sealfon Ross Bradley, ARXS's See Remarks, spent $350K of their own money on 12,500 shares at $28, growing their stake 1%.

+$350K
12,500 sh @ $28
ARXS
Buy Oetgen Stephen Duane · Director · Open-market purchase · filed Apr 20, 2026 ΔOwn +467%

Oetgen Stephen Duane, ARXS's Director, spent $700K of their own money on 25,000 shares at $28, growing their stake 467%.

+$700K
25,000 sh @ $28
Advertisement
ARXS
Buy ALLEN PATRICK E · Director · Open-market purchase · filed Apr 20, 2026 ΔOwn +187%

Allen Patrick E, ARXS's Director, spent $280K of their own money on 10,000 shares at $28, growing their stake 187%.

+$280K
10,000 sh @ $28
ARXS
Buy Perhamus Kevin Scott · Director, See Remarks · Open-market purchase · filed Apr 20, 2026 ΔOwn +1.5%

Perhamus Kevin Scott, ARXS's Director, spent $1.5M of their own money on 53,600 shares at $28, growing their stake 2%.

+$1.5M
53,600 sh @ $28
ARXS
Buy Roth Jason Aaron · See Remarks · Open-market purchase · filed Apr 20, 2026 ΔOwn +18%

Roth Jason Aaron, ARXS's See Remarks, spent $1.68M of their own money on 60,000 shares at $28, growing their stake 18%.

+$1.68M
60,000 sh @ $28
Advertisement

About ARXS insider activity

This page tracks every recent Form 4 filed for Arxis, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ARXS insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Arxis, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.